DPS Related Analyst Ratings
-
Credit Suisse Starts Dr Pepper Snapple (DPS) at Neutral
-
Sales of Energy Drinks Slows (MNST) (PEP) (KO)
-
BMO Capital Starts Dr Pepper Snapple (DPS) at Market Perform
-
Davenport Downgrades Dr Pepper Snapple (DPS) to Neutral
-
Poor Weather Leads to Softness in Beverage Trends, Says Goldman
-
Bernstein Downgrades Dr Pepper Snapple (DPS) to Market Perform
-
Green Mountain (GMCR) Losing K-Cup War; Private-Label Brands Selling for 50% Less
-
Firm Sees Green Mountain (GMCR)/Dr Pepper Snapple (DPS) Being 'Significant'
-
UBS Raises PT and Estimates on Dr Pepper Snapple (DPS); Thesis Is Still Limited Upside
-
Wells Fargo Upgrades Dr Pepper Snapple (DPS) to Outperform; Lower Commodity Prices Push EPS Up
-
Morgan Stanley Upgrades Dr Pepper Snapple (DPS) to Equalweight
-
Davenport Upgrades Dr Pepper Snapple (DPS) to Buy
-
UBS Cuts Estimates on Dr Pepper Snapple (DPS); Volumes Down, Ad Spending Likely Go Up
-
UBS Maintains a 'Neutral' on Dr Pepper Snapple (DPS); Cutting Estimates on Weak Volumes and Increased Competition
-
Goldman Sachs Upgrades Dr Pepper Snapple (DPS) to Neutral On Commodity Relief
-
Wells Fargo Downgrades Dr Pepper Snapple (DPS) to Market Perform; Fundamentals Have Stalled
-
BofA Starts KO, PEP, BEAM, STZ at Buy, DPS, CCE at Neutral, TAP at Underperform
-
Deutsche Bank Starts Dr Pepper Snapple (DPS) at Hold
-
Barclays Maintains an 'Equalweight' on Dr Pepper Snapple (DPS); It's Getting Late Early
-
Jefferies Maintains a 'Hold' on Dr Pepper Snapple (DPS); 3Q Wrap: CSD Volumes Holding On, Non-Carb Volumes Decelerating
-
Morgan Stanley Downgrades Dr Pepper Snapple (DPS) to Underweight
-
Morgan Stanley Starts Dr Pepper Snapple (DPS) at Equalweight
-
Barclays Downgrades Dr Pepper Snapple (DPS) to Equalweight
-
Goldman Sachs Says Better Pricing Will Power Beverage Stocks in the 2nd-Half (PEP) (KO) (DPS)
-
Jefferies Starts Dr Pepper Snapple (DPS) at Hold
-
Wells Fargo Starts Dr Pepper Snapple (DPS) at Outperform; A Cure For Ailing Consumer Staple Portfolio
-
Barclays on U.S. Consumer Staples: Removing RAH from our Consumer Staples 'Favorites' List
-
Barclays Maintains an 'Overweight' on Dr Pepper Snapple (DPS); Surprisingly Effervescent
-
UBS Maintains a 'Neutral' on Dr Pepper Snapple (DPS); Operationally Stronger than Expected
-
Deutsche Bank Downgrades Dr Pepper Snapple (DPS) to Hold on Valuation, as Catalysts Get Tougher
-
Goldman Sachs Downgrades Dr Pepper Snapple (DPS) to Sell
-
Stifel Nicolaus Cuts Dr Pepper Snapple (DPS) to Hold
-
Canaccord Genuity on Pepsico (PEP) and Coca-Cola (KO): Fizzing Out
-
Barclays Maintains an 'Overweight' on Dr Pepper Snapple (DPS); On the Road to Recovery
-
UBS on COGS Inflation and Pricing - Real Concerns
-
Canaccord Genuity Morning Coffee on Coca-Cola (KO) and Pepsico (PEP): Can’t Beat the Feeling
-
Q4 Preview: Pepsi (PEP) Looks to Keep Pace With Rivals (KO, DPS)
-
Goldman Cuts Target on Dr Pepper Snapple (DPS) from $41 to $39
-
Bernstein Starts Coca-Cola (KO), Pepsi (PEP), Dr Pepper Snapple (DPS) at Outperform, Coca-Cola Enterprises (CCE) at Market Perform
-
Dr Pepper Snapple (DPS) Cut from Outperform to Underperform at Credit Agricole
-
Deutsche Bank Upgraded Dr Pepper Snapple (DPS) to Buy On Valuation
-
Citi Maintains a 'Hold' on Coca-Cola Bottling (COKE); Lowering 2010 Estimate
-
Barclays Maintains an 'Overweight' Rating on Dr Pepper Snapple Group (DPS); Still on Call
-
Citi 2Q10 Earnings Preview on Beverages - Revenues Should Increase
-
UBS Cuts Rating on Dr Pepper Snapple (DPS), Cites Valuation Vs. Peers
-
UBS Cuts Dr Pepper Snapple Group (DPS) to Neutral; Shares Nose-Diving
-
Citi Reiterates a 'Buy' Rating on Dr Pepper Snapple Group (DPS); Remains our Favorite Beverage Stock
-
Credit Suisse Initiates Coverage on Dr Pepper Snapple Group (DPS) with a Neutral
-
Stifel Nicolaus Upgrades Dr Pepper Snapple Group (DPS) to Buy
-
Citi Maintains a 'Buy' on Dr Pepper Snapple Group (DPS); Raises PT & Estimates
Back to DPS Stock Lookup
